ProfileGDS4132 / 206024_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 16% 16% 19% 24% 21% 17% 21% 17% 23% 21% 27% 22% 24% 15% 36% 18% 20% 22% 21% 27% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10132.94516
GSM201543Muscle PCOS pioglitazone 12129.311316
GSM201544Muscle PCOS pioglitazone 16143.032919
GSM201545Muscle PCOS pioglitazone 20161.343324
GSM201829Muscle PCOS pioglitazone 23149.40421
GSM201830Muscle PCOS pioglitazon 25135.832317
GSM201831Muscle PCOS pioglitazone 27143.492721
GSM201832Muscle PCOS pioglitazone 3138.142317
GSM201833Muscle PCOS pioglitazone 4148.806723
GSM201834Muscle PCOS pioglitazone 8143.044221
GSM201835Muscle PCOS after pioglitazone 10250.653827
GSM201836Muscle PCOS after pioglitazone 12242.334622
GSM201837Muscle PCOS after pioglitazone 16245.309424
GSM201838Muscle PCOS after pioglitazone 20227.144115
GSM201839Muscle PCOS after pioglitazone 23283.016236
GSM201840Muscle PCOS after pioglitazone 25237.599818
GSM201841Muscle PCOS after pioglitazone 27234.147720
GSM201842Muscle PCOS after pioglitazone 3239.605922
GSM201843Muscle PCOS after pioglitazone 4247.640621
GSM201844Muscle PCOS after pioglitazone 8259.159427